Magritek

Wellington, New Zealand Founded: 2004 • Age: 22 yrs
Provider of NMR and MRI solutions for industries and research laboratories

About Magritek

Magritek is a Healthcare company based in Wellington (New Zealand) founded in 2004. It operates in the Healthcare and Technology sectors. Magritek has completed 1 acquisition, including NexMR. Its website magritek.com draws about 36 thousand monthly visits. Magritek offers products and services including Spinsolve, Autosampler, and Kea NMR-MOUSE. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems.

Company details

Provider of NMR and MRI solutions for industries and research laboratories. The companys products were initially developed by research teams at RWTH University, Germany, and Massey University, and Victoria University of Wellington in New Zealand. Its flagship analytical tool, Spinsolve NMR Spectrometer allows researchers to perform proton NMR spectra measurements within seconds. A single NMR scan using the instrument can measure concentrations and reveal molecular structure for many samples. Another product Terranova-MRI, the worlds first and only 3D MRI-capable of teaching system for students and teachers in a normal laboratory environment.

  • Headquarters Wellington, New Zealand
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website magritek.com
  • Social LinkedIn X
Key Metrics

Products & Services of Magritek

Magritek offers a comprehensive portfolio of products and services, including Spinsolve, Autosampler, and Kea NMR-MOUSE.

Spinsolve
Benchtop NMR Spectrometer

High-resolution device for monitoring chemical reactions in labs.

Autosampler
NMR Accessory

Enhances sample throughput for benchtop NMR systems.

Kea NMR-MOUSE
Specialized NMR Device

Portable tool for non-destructive material analysis.

Funding Insights of Magritek

  • Total Rounds 4
  • Investors Count 3

All 4 funding rounds of Magritek with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2021Series B––
Jan 2019$42,176Grant––
Oct 2014Series A––
Jul 2013Series A––
Valuation history

3 investors in total: 3 institutional.

Investors in Magritek

Magritek has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Ampersand Capital Partners and Rangatira Investments.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
ampersandcapital.comBoston, United States
Investment services are offered by Rangatira Investments in New Zealand.
rangatira.co.nzWellington, New Zealand
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Magritek

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Magritek

6 people are tracked at Magritek (3 in leadership, 2 in board & advisors, 1 in team).

NameRoleGroup
Federico Casanova
Director & Co-CEO Magritek GmbHLeadership
Juan Perlo
Co-CEO Magritek GmbHLeadership
Hector Robert
CEO, Magritek Inc.Leadership
Mark Dossor
DirectorBoard & advisors
Bernhard Blümich
DirectorBoard & advisors
Sanel Suljić
Senior Application Scientist & Regional Sales Manager EMEATeam
Premium access

Complete people profiles for Magritek

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Magritek

Magritek has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NexMR.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Software solutions for NMR-drug discovery pipelines are provided.
nexmr.comSwitzerland2021Jul 2026β€’β€’β€’β€’
Premium access

Complete acquisition details for Magritek

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Magritek

4 dated milestones of Magritek across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded Magritek is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series B,.
  4. Acquisition Acquires NexMR.

Web traffic of Magritek

The website of Magritek (magritek.com) receives about 35.5K visits a month.

  • Monthly visits
    35.5K

    ▲ 18.4% vs previous month

Similar websites

Websites whose visitors overlap most with Magritek. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bruker.com
100%
346K#136,650View details
aiinmr.com
aiinmr.com
96%
#3,358,955–
tecmag.com
96%
1K#14,672,646View details
progression-systems.com
91%
View details
dotynmr.com
83%
4.1K#4,168,019View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 36 similar websites and full traffic analytics for Magritek

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 36 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Magritek

Premium access

Complete news archive for Magritek

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Magritek

Magritek was founded in 2004 and raised its 1st funding round 9 years after it was founded.

Magritek is headquartered in Wellington, New Zealand.

Provider of NMR and MRI solutions for industries and research laboratories. The companys products were initially developed by research teams at RWTH University, Germany, and Massey University, and Victoria University of Wellington in New Zealand. Its flagship analytical tool, Spinsolve NMR Spectrometer allows researchers to perform proton NMR spectra measurements within seconds. A single NMR scan using the instrument can measure concentrations and reveal molecular structure for many samples. Another product Terranova-MRI, the worlds first and only 3D MRI-capable of teaching system for students and teachers in a normal laboratory environment.

Magritek offers Spinsolve, Autosampler, and Kea NMR-MOUSE.

Magritek has made 1 acquisition, including NexMR.

Magritek has 3 investors. Key investors include European Union, Ampersand Capital Partners, and Rangatira Investments.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available